Igniting Transformative Medicine 2026
Accelerating the AMR response
Bringing together healthcare leaders, researchers, innovators, and industry to accelerate next-generation solutions in diagnostics, vaccines, and anti-infectives against antimicrobial resistance.
America Square, London
Thursday 26th November 2026
Chaired and guided by:
Phil Packer - Innovation Lead AMR and Vaccine, Innovate UK
In association with
Free to Attend
CPD Accredited
Expert Insight
Panel Debates
Coffee & Lunch
Why this event matters
Tackling the Future of AMR
Antimicrobial resistance is one of the greatest challenges facing global healthcare, creating an urgent need for innovative antimicrobial and diagnostic technologies that can be developed, funded, and adopted more quickly. Overcoming this challenge requires collaboration between government, healthcare, regulators, funders, researchers, and industry.
Supported by Innovate UK and BIVDA, this conference brings together the organisations shaping the UK's AMR innovation landscape. Through expert presentations, interactive discussions, and dedicated networking, delegates will gain practical insight into funding, regulation, commercialisation, and collaboration—helping transform breakthrough ideas into real-world healthcare solutions.
What makes IGNITING TRANSFORMATIVE MEDICINE different
A practical event focused on accelerating AMR innovation.
Government & Healthcare Leadership
Hear directly from government, NHS England, UKHSA, and national healthcare leaders on the priorities, challenges, and opportunities shaping the UK's response to antimicrobial resistance.
Funding & Innovation Support
Gain insight into the organisations supporting AMR innovation, including funding opportunities, investment priorities, and the programmes helping innovators move technologies towards market.
From Innovation to Implementation
Explore the practical steps involved in developing and deploying new antimicrobial and diagnostic technologies, from intellectual property and regulation to commercialisation and NHS adoption.
Collaboration That Creates Impact
Connect with researchers, innovators, funders, regulators, investors, healthcare leaders, and industry partners through expert-led sessions and dedicated networking designed to build meaningful collaborations.
Designed for decision-makers
Bringing Together the Organisations Driving AMR Innovation
Academic Research & Vaccine Science
Researchers, microbiologists, immunologists, and translational science teams focused on advancing vaccines, infection prevention, and antimicrobial resistance innovation.
Academic Research
Vaccine Development
Microbiology
Translational Science
Pharmaceutical & Biotechnology
Biotechnology companies, pharmaceutical developers, and anti-infective research teams working on next-generation therapeutics, vaccines, and precision treatments.
Anti-Infectives
Therapeutic Development
Biotechnology
Drug Discovery
Diagnostics & Health Technology
Diagnostics developers, in vitro diagnostics companies, and health technology innovators developing faster, smarter, and more precise infection detection solutions.
IVD Development
Clinical Diagnostics
Health Technology
Point-of-Care Innovation
Funding, Commercialisation & Partnerships
Investors, innovation agencies, technology transfer offices, incubators, and commercialisation specialists supporting healthcare innovation from research to market deployment.
Investment & Funding
Commercialisation
Technology Transfer
Strategic Partnerships
Speakers
Chi Onwurah MP
Chair - Science, Innovation and Technology Committee
[Proposed]
Dr. Bev Isherwood
Programme Director - PACE
[Confirmed]
Dr. Jayne Ellis
Scientific Lead - BIVDA
[Confirmed]
Dr. Kerrie Davies MBE
Consultant Clinical Scientist and Head of HCAI Research Group Laboratory/Honorary Associate Professor in Diagnostics for Infectious Disease - Leeds Teaching Hospitals NHS Trust/University of Leeds
[Confirmed]
Dr. Mariyam Mirfenderesky
Consultant in Medical Microbiology – North Middlesex University Hospital – UKHSA
[Invited]
Helena Costa Pereira
Communications Lead – INCATE Europe
[Proposed]
Melanie Amphlett
Head of Operations - UKHSA Diagnostic Accelerator
[Proposed]
Phil Packer
Innovation Lead – AMR & Vaccines – Innovate UK
[Confirmed]
Prof. Jane Freeman
Professor of AMR and Infection/Honorary Clinical Scientist - University of Leeds/Leeds Teaching Hospitals NHS Trust
[Confirmed]
Prof. Mark Wilcox
National Clinical Director – AMR & IPC – NHS England
[Invited]
Prof. Victoria Chalker
Deputy Chief Scientific Officer - NHS England
[Confirmed]
Vega Masignani
Alliance Director - Carb-X
[Proposed]